Genmab A (GMAB) Exchange Rate Effect (2020 - 2026)

Genmab A (GMAB) has reported Exchange Rate Effect for 6 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Exchange Rate Effect rose 33.33% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (down 90.0% YoY), and the FY2025 full-year result was $3.0 million, down 95.24% from the prior year.
• Exchange Rate Effect advanced to $4.0 million in Q2 2026 per GMAB's latest filing, from -$11.0 million in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $34.0 million in Q3 2024 and bottomed at -$216.0 million in Q1 2023.
• Historically, Exchange Rate Effect has averaged -$19.9 million across 4 years, with a median of $1.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 900.0% in 2025, then plunged 237.5% in 2026.
• Over 4 years, Exchange Rate Effect stood at -$12.0 million in 2023, then soared by 383.33% to $34.0 million in 2024, then sank by 79.41% to $7.0 million in 2025, then slumped by 42.86% to $4.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered $4.0 million, -$11.0 million, and $7.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.